![Lawrence T. Friedhoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence T.
Friedhoff worked as the Chief Executive Officer & Director at Senex Biotechnology, Inc. and as the Chief Development Officer at Axovant Sciences, Inc.
| Unternehmen | Position | Ende |
|---|---|---|
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 28.09.2017 |
Senex Biotechnology, Inc.
 Senex Biotechnology, Inc. BiotechnologyHealth Technology Develops oncology drugs | Vorstandsvorsitzender | 02.01.2014 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Senex Biotechnology, Inc.
Senex Biotechnology, Inc. BiotechnologyHealth Technology Develops oncology drugs | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
